Exacerbation of psoriasis following hydroxychloroquine in a patient with suspected COVID‐19
- 24 January 2021
- journal article
- letter
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 34 (2), e14806
- https://doi.org/10.1111/dth.14806
Abstract
Click on the article title to read more.Keywords
This publication has 8 references indexed in Scilit:
- Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatmentJournal of the American Academy of Dermatology, 2020
- Characterizing the adverse dermatologic effects of hydroxychloroquine: A systematic reviewJournal of the American Academy of Dermatology, 2020
- COVID-19 and biologics for psoriasis: A high-epidemic area experience-Bergamo, Lombardy, ItalyJournal of the American Academy of Dermatology, 2020
- A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID ‐19: Will cases of psoriasis increase after COVID ‐19 pandemic?Dermatologic Therapy, 2020
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitroCell Discovery, 2020
- Hydroxychloroquine-Induced Psoriasis-form Erythroderma in a Patient with Systemic Lupus ErythematosusChinese Medical Journal, 2018
- Drug-induced psoriasis: clinical perspectivesPsoriasis: Targets and Therapy, 2017
- Long-term oral azithromycin in chronic plaque psoriasis: a controlled trialEuropean Journal of Dermatology, 2010